Harvard Medical School Q-FASTR logo
Harvard Q-FASTR Therapeutics Acceleration Grants

Q-FASTR Pilot Award

Supports Harvard investigators with early funding for biomedical trials and validation.

ClosedHarvard Medical School Q-FASTRUnited States
View on funder site
About

The Q-FASTR Pilot Award is administered by Q-FASTR (Quadrangle Fund for Advancing and Seeding Translational Research), an initiative within Harvard Medical School's Innovation Hub (I-Hub) under the Office of the Dean. Q-FASTR was established in 2014 through an initial philanthropic gift from Phill Gross, subsequently matched by grants from the Warren Alpert Foundation and Barbara and Louis Perlmut…

What this grant funds

Early-stage therapeutics: protein therapeutics, small molecules, gene therapies, oligonucleotides, cell therapies, computational approaches, screening technologies, diagnostics.

Key facts
CycleiHow often this grant runs — e.g. annually, on a rolling basis, or a one-off call.Annual
Next deadlineiThe next date applications are due. Rolling means you can apply any time.—
Decision timeiTypical time from the deadline to the funder's decision.—
Project durationiHow long the funded work is expected to run.null–12 months
Award typeiThe form of funding — grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.—
Funding analytics

Sign up free to see the funding breakdown

Create free accountSign in
Industries

Sign up free to see the industries in scope

Create free accountSign in
Eligibility criteria

Sign up free to see the full eligibility

Create free accountSign in
Application process

Sign up free to see how to apply

Create free accountSign in
What you have to submit

Sign up free to see what you submit

Create free accountSign in
Timeline

Sign up free to see the timeline

Create free accountSign in
Last verified: 24 Jul 2026Source: qfastr.hms.harvard.edu